Opportunities & Announcements

All NIAID-relevant grant funding opportunity announcements (FOAs) are listed here. Find amendments inside the FOAs. Subscribe for Email Updates for our opportunities. Also see NIAID Contract Solicitations or Find a Foundation or Other Funding Source outside NIH.

Showing results filtered by:
Title Activity Code Posting Date Expiration Date
HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-003 UM1 January 24, 2019 August 2, 2019
HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-004 UM1 January 24, 2019 August 2, 2019
HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-005 UM1 January 24, 2019 August 2, 2019
HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-006 UM1 January 24, 2019 August 2, 2019
HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required)- RFA-AI-19-001 UM1 January 24, 2019 August 2, 2019
HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1 Clinical Trial Required)- RFA-AI-19-002 UM1 January 24, 2019 August 2, 2019
HIV-1 Infection of the Central Nervous System (R01)- PA-17-100 R01 January 5, 2017 January 8, 2020
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)- PAR-18-319 P01 October 13, 2017 March 14, 2020
Genetic Engineering Technologies for HIV Cure Research (U19 Clinical Trial Optional)- RFA-AI-18-058 U19 November 29, 2018 March 12, 2019
Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed)- RFA-AI-18-053 R01 November 13, 2018 March 14, 2019
Long-acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed)- RFA-AI-18-057 R61/R33 November 20, 2018 March 14, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R41/R42)- PA-16-182 R41/R42 April 12, 2016 April 6, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R43/R44)- PA-16-184 R43/R44 April 12, 2016 April 6, 2019
The Use of mRNA for an HIV Envelope Vaccine (R43/R44)- PA-16-207 R43/R44 April 19, 2016 April 6, 2019
The Use of mRNA for an HIV Envelope Vaccine (R41/R42)- PA-16-208 R41/R42 April 19, 2016 April 6, 2019
Innovation for HIV Vaccine Discovery (R01)- PAR-17-263 R01 April 25, 2017 August 2, 2019
Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required)- RFA-AI-18-022 U01 June 28, 2018 October 10, 2019
Detection of HIV for Self-Testing (R61/R33)- PAR-17-471 R61/R33 August 25, 2017 December 7, 2019
Eradication of HIV-1 From Central Nervous System Reservoirs (R01)- PA-17-084 R01 December 13, 2016 January 8, 2020
Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)- PA-17-113 R01 January 9, 2017 January 8, 2020
NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)- PA-17-114 R01 January 9, 2017 January 8, 2020
Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)- PAR-18-411 R01 November 16, 2017 March 14, 2020
Imaging the Persistent HIV Reservoir (R01)- PA-17-305 R01 June 6, 2017 May 8, 2020
Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)- PA-17-306 R21 June 7, 2017 May 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)- PA-17-282 R21 May 12, 2017 September 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)- PA-17-283 R01 May 12, 2017 September 8, 2020
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional)- PA-18-651 R01 February 12, 2018 January 8, 2021
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed)- PA-18-652 R21 February 12, 2018 January 8, 2021
CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed) - PAR-18-895 R01 August 8, 2018 January 8, 2021
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)- PAR-18-923 R21 September 17, 2018 January 15, 2021
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional)- PA-18-753 R01 April 11, 2018 May 8, 2021
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trial Not Allowed)- PA-18-754 R21 April 11, 2018 May 8, 2021
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)- PAR-18-764 R01 April 20, 2018 May 8, 2021
Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)- PA-19-042 R01 November 1, 2018 September 8, 2021
Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)- PA-19-050 R21 November 1, 2018 September 8, 2021
Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)- PAS-19-097 R01 November 29, 2018 January 8, 2022